Most cited papers from Natera (United States)

Natera (United States)

What are the most cited papers from Natera (United States)?

The most cited paper from Natera (United States) is "Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution" (Christopher Abbosh et al., 2017), with 1,978 citations. Next come "Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer" (1,054) and "ctDNA guiding adjuvant immunotherapy in urothelial carcinoma" (648).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 77 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution Christopher Abbosh et al. · Nature Open access104 authors	25 Apr 2017	1,978
2	Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer Thomas Reinert et al. · JAMA Oncology Open access	9 May 2019	1,054
3	ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Thomas B. Powles et al. · Nature	16 Jun 2021	648
4	Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma Emil Christensen et al. · Journal of Clinical Oncology Open access	6 May 2019	566
5	Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence Raoul Charles Coombes et al. · Clinical Cancer Research Open access	16 Apr 2019	531
6	Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer Daisuke Kotani et al. · Nature Medicine Open access	2023	515
7	Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab Scott Victor Bratman et al. · Nature Cancer	3 Aug 2020	503
8	Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival Mark Jesus M. Magbanua et al. · Annals of Oncology Open access	21 Nov 2020	463
9	Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup Logan C. Walker et al. · The American Journal of Human Genetics Open access	22 Jun 2023	354
10	Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes Ronald J. Wapner, Joshua Babiarz, Brynn Levy et al. · American Journal of Obstetrics and Gynecology Open access	2 Dec 2014	338
11	Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci Bernhard G Zimmermann, Matthew Davenport Hill, George Gemelos et al. · Prenatal Diagnosis Open access	30 Oct 2012	332
12	Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort Eugene Pergament, Howard Cuckle, Bernhard G Zimmermann et al. · Obstetrics and Gynecology Open access	8 Jul 2014	287
13	Clinical experience and follow-up with large scale single-nucleotide polymorphism–based noninvasive prenatal aneuploidy testing Pe'er Dar, Kirsten J. Curnow, Susan Joy Gross et al. · American Journal of Obstetrics and Gynecology Open access	8 Aug 2014	278
14	Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA Jinglan Zhang et al. · Nature Medicine	28 Jan 2019	275
15	Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences Tenna Vesterman Henriksen et al. · Clinical Cancer Research Open access	Oct 2021	261
16	ctDNA-based molecular residual disease and survival in resectable colorectal cancer Yoshiaki Nakamura et al. · Nature Medicine Open access	16 Sep 2024	249
17	Evidence of Selection against Complex Mitotic-Origin Aneuploidy during Preimplantation Development Rajiv C. McCoy, Zachary Demko, Allison Ryan et al. · PLoS Genetics Open access	22 Oct 2015	235
18	Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer Mark Magdi Awad et al. · Cancer Cell Open access	25 Aug 2022	234
19	Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR Tara K. Sigdel, Felipe Acosta Archila, Tudor P. Constantin et al. · Journal of Clinical Medicine Open access	23 Dec 2018	220
20	Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism–based noninvasive prenatal test Kirsten J. Curnow, Louise E. Wilkins-Haug, Allison Ryan et al. · American Journal of Obstetrics and Gynecology Open access	15 Oct 2014	219
21	Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism–based preimplantation genetic screening Zachary Demko, Alexander L. Simon, Rajiv C. McCoy et al. · Fertility and Sterility Open access	8 Feb 2016	215
22	Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder Bernadett Emma Szabados et al. · European Urology Open access	13 May 2022	207
23	Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy Mark Jesus M. Magbanua et al. · Cancer Cell Open access	4 May 2023	194
24	Practical recommendations for using ctDNA in clinical decision making Stacey A. Cohen, Minetta C. Liu, Alexey A. Aleshin · Nature	12 Jul 2023	171
25	The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA Tenna Vesterman Henriksen, Thomas Reinert, Emil Christensen et al. · Molecular Oncology Open access	29 May 2020	169
26	Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer Mariam Jamal‐Hanjani, Gareth A. Wilson, Stuart D. Horswell et al. · Annals of Oncology Open access	28 Jan 2016	168
27	Origins and rates of aneuploidy in human blastomeres Matthew J. Rabinowitz, Allison Ryan, George Gemelos et al. · Fertility and Sterility Open access	21 Dec 2011	159
28	CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer Hiroya Taniguchi, Yoshiaki Nakamura, Daisuke Kotani et al. · Cancer Science Open access	May 2021	156
29	Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma Thomas B. Powles, Zoe June F. Assaf, Viraj Degaonkar et al. · European Urology	26 Jul 2023	150
30	Clinical experience with single‐nucleotide polymorphism‐based non‐invasive prenatal screening for 22q11.2 deletion syndrome Susan Joy Gross, Melissa Stosic, Donna M. McDonald‐McGinn et al. · Ultrasound in Obstetrics and Gynecology Open access	23 Sep 2015	149
31	Evaluation of Telemedicine for Screening of Diabetic Retinopathy in the Veterans Health Administration Eser Kırkızlar, Nicoleta Serban, Jennifer A. Sisson et al. · Ophthalmology	29 Sep 2013	147
32	SNP‐based non‐invasive prenatal testing detects sex chromosome aneuploidies with high accuracy Carole A. Samango‐Sprouse, Milena Banjevic, Allison Ryan et al. · Prenatal Diagnosis Open access	24 May 2013	145
33	The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies Philip F. Halloran, Jeff Reeve, Katelynn S. Madill-Thomsen et al. · Journal of the American Society of Nephrology Open access	20 Jan 2022	141
34	A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes Joshua James Gruber, Anosheh Afghahi, Kirsten M. Timms et al. · Nature Cancer Open access	17 Oct 2022	135
35	Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity S.Y. Cindy Yang et al. · Nature Communications Open access	26 Aug 2021	130
36	Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases Fotios Loupakis et al. · JCO Precision Oncology Open access	21 Jul 2021	130
37	Common variants spanning PLK4 are associated with mitotic-origin aneuploidy in human embryos Rajiv C. McCoy, Zachary Demko, Allison Ryan et al. · Science Open access	9 Apr 2015	129
38	Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial Yara L. Verschoor et al. · Nature Medicine Open access	8 Jan 2024	117
39	Clinical experience with a single‐nucleotide polymorphism‐based non‐invasive prenatal test for five clinically significant microdeletions Kimberly A. Martin, Shanto Iyengar, A. Kalyan et al. · Clinical Genetics Open access	11 Jul 2017	113
40	The type of feto‐placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure Francesca Romana Grati, Komal Bajaj, Francesca Malvestiti et al. · Prenatal Diagnosis	27 Jul 2015	112
41	Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study Brigitta Derendinger et al. · The Lancet Microbe Open access	3 Nov 2023	111
42	A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs Derrick S. Haslem, Sofya Norman, Gail L. Fulde et al. · Journal of Oncology Practice Open access	6 Sep 2016	104
43	Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy Hussein Sultan et al. · Nature Open access	24 Jul 2024	103
44	Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel Michael T. Parsons et al. · The American Journal of Human Genetics Open access	13 Aug 2024	99
45	A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women Yiwey Shieh et al. · JNCI Journal of the National Cancer Institute Open access	23 Sep 2019	94
46	The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease Neera K. Dahl, Michelle S. Bloom, Fouad T. Chebib et al. · Journal of the American Society of Nephrology Open access	5 Oct 2023	92
47	Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach Maggie A. Westemeyer, Jennifer B. Saucier, Jody Wallace et al. · Genetics in Medicine Open access	4 May 2020	91
48	Reliability of 46,XX results on miscarriage specimens: a review of 1,222 first-trimester miscarriage specimens Ruth Bunker Lathi, Stephanie L. F. Gustin, Jennifer L. Keller et al. · Fertility and Sterility Open access	29 Oct 2013	89
49	Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors Pashtoon M. Kasi et al. · JCO Precision Oncology Open access	9 Mar 2022	85
50	Pregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations Dennis Idowu, Katrina Merrion, Nina Wemmer et al. · Fertility and Sterility Open access	21 Feb 2015	85

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.